在当代高风险皮肤冠状动脉干预后排气分数的改善:RESTORE EF研究结果
Jason Wollmuth1, Mitul P Patel2, Thom Dahle3
1Providence Heart and Vascular Institute, Portland, Oregon.
概括
通过Impella支持的高风险穿皮冠状动脉干预 (HRPCI) 在90天内改善了左心室喷射率 (LVEF). 在这些患者中,完整的复血管化进一步提高了LVEF的改善.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 在血液动力学支持的高风险穿皮冠状动脉干预 (HRPCI) 后,对左心室喷射率 (LVEF) 改善的数据有限.
- 以前的报道集中在临床结果上,而不是特别关注该患者组的LVEF变化.
研究的目的:
- 评估Impella支持的HRPCI在中期随访时对左心室功能的影响.
- 在接受HRPCI与血液动力学支持的理想患者队列中评估LVEF的变化.
主要方法:
- 恢复EF:对前性收集的数据进行多中心的回顾性分析.
- 评估了90天的LVEF在患者中幸存的非出现HRPCI与Impella支持.
- 二级终点包括纽约心脏协会 (NYHA) 和加拿大心血管学会 (CCS) 评分的变化.
主要成果:
- 在251名患者的90天随访 (P < .0001) 后,基线LVEF从35%提高到45%.
- 在残留SYNTAX得分为0.0的患者中,观察到更大的LVEF改善.
- 在NYHA等级III/IV (62%至15%) 和CCS等级III/IV (72%至2%) 的症状中,有显著的减少.
结论:
- 在血液动力学支持的HRPCI中,在理想患者队列中,90天的LVEF显著改善.
- 完整的复血管化与更大的LVEF改善有关.
- 结果是产生假设的,需要在更大的研究和随机试验中进行进一步的调查.
更多相关视频
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...